de Bono D P
Department of Cardiology, University of Leicester, Glenfield General Hospital, UK.
Z Kardiol. 1993;82 Suppl 2:147-51.
Serious bleeding complications are 'thankfully' a rare complication of thrombolytic therapy. Careful case selection and meticulous invasive techniques are important contributors to this. Early recognition of bleeding, prompt termination of thrombolysis, administration of plasmin inhibitors and fibrinogen repletion are the major steps in correcting the haemostatic defect. Allergic complications are also rare, particularly with alteplase or urokinase. These agents should be used electively in all patients previously exposed to streptokinase or anistreplase. Most allergic reactions are self-terminating and do not lead to long-term sequelae. Iatrogenic complications of catheter insertion can be avoided by technically-correct and careful catheter placement, but unnecessary vascular intervention should be avoided.
严重出血并发症是溶栓治疗“所幸”较为罕见的并发症。仔细的病例选择和精细的侵入性技术对此起到了重要作用。早期识别出血、及时终止溶栓、给予纤溶酶抑制剂和补充纤维蛋白原是纠正止血缺陷的主要步骤。过敏并发症也很罕见,尤其是使用阿替普酶或尿激酶时。对于所有既往接触过链激酶或茴酰化纤溶酶原链激酶激活剂复合物的患者,应选择性使用这些药物。大多数过敏反应可自行终止,不会导致长期后遗症。通过技术正确且仔细的导管放置可避免导管插入的医源性并发症,但应避免不必要的血管介入。